About EarliPoint Health

EarliPoint Health delivers a breakthrough, FDA-cleared eye-tracking technology designed to help autism service providers diagnose earlier, treat sooner, and measure outcomes. Developed over more than two decades of peer-reviewed research at Emory University and Children’s Healthcare of Atlanta, EarliPoint captures hundreds of data points per second to analyze a child’s moment-by-moment looking behavior against typical developmental milestones. This provides clinicians with objective, clinically validated insights that support both diagnostic decision-making and ongoing outcomes monitoring.

Autism service providers across the country, many of whom rely on Netsmart solutions, are facing unprecedented demand and widening gaps in care. The median age of autism diagnosis in the United States remains 4–5 years old, despite clear evidence that earlier identification leads to better outcomes. However, access to qualified diagnosticians is limited, waitlists are growing, and many organizations lack standardized tools to support consistent, timely evaluations.

EarliPoint’s FDA-cleared technology aligns directly with these needs. By providing a rapid, objective assessment that enhances clinical workflows, EarliPoint helps organizations streamline assessments, expand access, and deliver earlier answers to families. The ability to use EarliPoint for ongoing outcomes monitoring gives providers a consistent, objective way to evaluate intervention effectiveness and prepare for the emerging shift toward measurable outcomes and value-based care. Together, EarliPoint Health and Netsmart are dedicated to advancing solutions that enhance clinical decision-making, increase access to timely care, and drive better outcomes for children and families.